These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2127654)

  • 41. [New trends in the management of Rh factor isoimmunization].
    García Alonso A; Amor Calleja L; Manterola Alvarez AD; Andrade Jiménez MV; García Tagle J; Echeverría JL
    Ginecol Obstet Mex; 1985 Nov; 53():291-5. PubMed ID: 3939131
    [No Abstract]   [Full Text] [Related]  

  • 42. [Intrauterine management of Rh-alloimmunization].
    Intödy Z; Hajdu K; Réti M; Gombos S; Mészáros J; Vörös J; Jakab J; Hoffer I; Doszpod J
    Orv Hetil; 1996 Mar; 137(13):675-9. PubMed ID: 8649747
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Growth of the human fetus. II. Abnormal growth in twins and infants of mothers with diabetes, hypertension, or isoimmunization.
    Gruenwald P
    Am J Obstet Gynecol; 1966 Apr; 94(8):1120-32. PubMed ID: 5006427
    [No Abstract]   [Full Text] [Related]  

  • 44. [Accumulation of two different hydroxyethyl starch preparations in the placenta after hemodilution in patients with fetal intrauterine growth retardation or pregnancy hypertension].
    Heilmann L; Lorch E; Hojnacki B; Müntefering H; Förster H
    Infusionstherapie; 1991 Oct; 18(5):236-43. PubMed ID: 1722779
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Feto-maternal blood immunization. Physiopathology, diagnosis, treatment].
    Gaucherand P; Rudigoz RC
    Rev Prat; 1990 May; 40(14):1329-34. PubMed ID: 2113708
    [No Abstract]   [Full Text] [Related]  

  • 46. Plasma exchange and high-dose i.v. immunoglobulin in the treatment of severe rhesus hemolytic disease.
    Berlin G; Selbing A; Gottvall T
    Prog Clin Biol Res; 1990; 337():337-40. PubMed ID: 2112753
    [No Abstract]   [Full Text] [Related]  

  • 47. Monitoring and treatment of anti-D in pregnancy.
    Bettelheim D; Panzer S; Reesink HW; Csapo B; Pessoa C; Guerra F; Wendel S; Calda P; Sprogøe U; Dziegiel M; Aitokallio-Tallberg A; Koskinen S; Kuosmanen M; Legler TJ; Stein W; Villa S; Villa MA; Trespidi L; Acaia B; Vandenbussche FP; Brand A; de Haas M; Kanhai HH; Gounder D; Flanagan P; Donegan R; Parry E; Sefonte C; Skulstad SM; Hervig T; Flesland Ø; Zupańska B; Uhrynowska M; Lapaire O; Zhong XY; Holzgreve W
    Vox Sang; 2010 Aug; 99(2):177-92. PubMed ID: 20331536
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Characteristics of the course and management of pregnancy and labor in uterine myoma].
    Bunin AT; Shmakov GS
    Akush Ginekol (Mosk); 1980 Jan; (1):31-3. PubMed ID: 7377473
    [No Abstract]   [Full Text] [Related]  

  • 49. [Prevention of fetal erythroblastosis with anti-D immunoglobulin].
    Rasteński J; Gryglicka M
    Acta Haematol Pol; 1988; 19(3-4):239-41. PubMed ID: 3150900
    [No Abstract]   [Full Text] [Related]  

  • 50. [Antepartum CTG: extreme growth retardation and choice of delivery time].
    Baumann P; Künzel W
    Gynakologe; 1992 Feb; 25(1):41-3. PubMed ID: 1547981
    [No Abstract]   [Full Text] [Related]  

  • 51. Rh isoimmunization complicating a triplet gestation. A case report.
    Gast MJ; Rigg LA; Martin CM
    J Reprod Med; 1991 Apr; 36(4):306-8. PubMed ID: 1906542
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reversion of the Ballantyne syndrome despite fetal hydrops persistence.
    Lobato G; Nakamura-Pereira M
    Fetal Diagn Ther; 2008; 24(4):474-7. PubMed ID: 19047795
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevention and management of RhD isoimmunization.
    Harkness UF; Spinnato JA
    Clin Perinatol; 2004 Dec; 31(4):721-42, vi. PubMed ID: 15519425
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Albumin and packed red blood cells in the treatment of severely isoimmunised pregnancies.
    Marianowski L; Debski R; Rokicki T; Pasek K; Lukaszewicz E; Gromadzki J
    Mater Med Pol; 1992; 24(4):260-1. PubMed ID: 1308057
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Toxemia of pregnancy and retardation of fetal growth (author's transl)].
    Zhang ZJ
    Zhonghua Fu Chan Ke Za Zhi; 1981 Jan; 16(1):6-9. PubMed ID: 7297240
    [No Abstract]   [Full Text] [Related]  

  • 56. [Clinical significance of pregnancy-specific beta 1-glycoprotein analysis in endocrine tests of the gonadal and placental system].
    Mochizuki M
    Nihon Rinsho; 1989 Dec; 48 Suppl():1274-8. PubMed ID: 2560074
    [No Abstract]   [Full Text] [Related]  

  • 57. [Intrauterine fetal transfusion in twin pregnancy with Rh isoimmunization].
    Vasileva Iu; Poissonier ME
    Akush Ginekol (Sofiia); 1989; 28(1):33-6. PubMed ID: 2500863
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Maternal mortality in HELLP syndrome in Bavaria 1983-1992].
    Welsch H; Krone HA
    Zentralbl Gynakol; 1994; 116(4):202-6. PubMed ID: 8023605
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Feto-maternal alloimmunization].
    Thoumsin H
    Rev Med Liege; 1988 Nov; 43(22):743-5. PubMed ID: 3146792
    [No Abstract]   [Full Text] [Related]  

  • 60. ACOG releases report on prevention of D isoimmunization.
    Am Fam Physician; 1991 Jan; 43(1):307-8, 310. PubMed ID: 1846056
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.